Qian Cheng

1.1k total citations
25 papers, 883 citations indexed

About

Qian Cheng is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Qian Cheng has authored 25 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 5 papers in Surgery. Recurrent topics in Qian Cheng's work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer Research and Treatments (4 papers). Qian Cheng is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer Research and Treatments (4 papers). Qian Cheng collaborates with scholars based in China and United States. Qian Cheng's co-authors include Jiandong Chen, Lihong Chen, Zhenyu Li, Baozong Li, William S. Lane, Xiaofei Zhang, Gong Yang, Huijing Yin, Changhong Miao and Zhi-Min Yuan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Qian Cheng

25 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qian Cheng China	18	607	450	167	91	87	25	883
Houjie Liang China	19	459 0.8×	238 0.5×	215 1.3×	65 0.7×	107 1.2×	36	862
Xin Shi China	10	401 0.7×	237 0.5×	103 0.6×	202 2.2×	92 1.1×	34	723
Alexander Gheldof Belgium	11	660 1.1×	437 1.0×	285 1.7×	140 1.5×	70 0.8×	26	1.1k
Daniela Annibali Belgium	18	601 1.0×	295 0.7×	257 1.5×	51 0.6×	59 0.7×	29	1.0k
Gina M. Sizemore United States	13	472 0.8×	300 0.7×	204 1.2×	78 0.9×	36 0.4×	27	792
Caroline H. Diep United States	11	376 0.6×	574 1.3×	191 1.1×	145 1.6×	82 0.9×	15	1.1k
Jenean O’Brien United States	13	356 0.6×	590 1.3×	229 1.4×	93 1.0×	72 0.8×	15	1.1k
Goodwin G. Jinesh United States	19	627 1.0×	305 0.7×	162 1.0×	96 1.1×	105 1.2×	32	973
Isabelle Soubeyran France	14	369 0.6×	362 0.8×	168 1.0×	69 0.8×	76 0.9×	25	767
Aytekin Akyol Türkiye	14	464 0.8×	313 0.7×	151 0.9×	59 0.6×	116 1.3×	40	964

Countries citing papers authored by Qian Cheng

Since Specialization

Citations

This map shows the geographic impact of Qian Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Cheng more than expected).

Fields of papers citing papers by Qian Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Cheng. The network helps show where Qian Cheng may publish in the future.

Co-authorship network of co-authors of Qian Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Cheng. A scholar is included among the top collaborators of Qian Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Cheng. Qian Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Shengyu, Qian Cheng, Yang Shi, et al.. (2025). LncRNA PVT1 activated by TGF-β1/Smad3 facilitates proliferation and metastasis of hepatocellular carcinoma via upregulating Smad6 and NRG1. Journal of Translational Medicine. 23(1). 500–500. 1 indexed citations

Cheng, Qian, et al.. (2024). Efficacy and safety in early application of Ruxolitinib for high-risk acute lymphoblastic leukemia to prevent GVHD and recurrence after allogeneic hematopoietic stem cell transplantation. Transplant Immunology. 83. 101978–101978. 1 indexed citations

Xiao, Xiang, Ziyang Liu, Chong Zhang, et al.. (2021). IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma. Advanced Science. 8(17). e2101230–e2101230. 48 indexed citations

Liu, Huan, Qian Cheng, Dongsheng Xu, et al.. (2020). Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells. Respiratory Research. 21(1). 287–287. 20 indexed citations

Xiao, Hualiang, Qian Cheng, Xiaoyan Wu, et al.. (2019). ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway. SHILAP Revista de lepidopterología. 1 indexed citations

Gao, Xiaoge, Qian Zhang, Qian Liu, et al.. (2019). Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 362–362. 27 indexed citations

Li, Zhao, et al.. (2019). Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma. Journal of Clinical Pathology. 72(4). 295–303. 4 indexed citations

Yang, Leixiang, Tanjing Song, Qian Cheng, Lihong Chen, & Jiandong Chen. (2018). Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity. Molecular and Cellular Biology. 39(4). 18 indexed citations

Zhang, Xiaofei, Qian Cheng, Huijing Yin, & Gong Yang. (2017). Regulation of autophagy and EMT by the interplay between p53 and RAS during cancer progression (Review). International Journal of Oncology. 51(1). 18–24. 45 indexed citations

10.

Chen, Wankun, Yajun Xu, Jing Zhong, et al.. (2016). MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway. Oncotarget. 7(48). 78726–78735. 35 indexed citations

11.

Cheng, Qian, et al.. (2015). Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 71(2). 147–154. 55 indexed citations

12.

Cheng, Qian, Tanjing Song, Lihong Chen, & Jiandong Chen. (2014). Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction. Molecular and Cellular Biology. 34(15). 2800–2810. 20 indexed citations

13.

Tang, Jun, Qian Cheng, Like Qu, et al.. (2013). Correction: Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation. PLoS ONE. 8(9). 29 indexed citations

14.

Tang, Jun, Qian Cheng, Like Qu, et al.. (2013). Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation. PLoS ONE. 8(2). e55813–e55813. 24 indexed citations

15.

Chen, Lihong, et al.. (2011). Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain. Journal of Biological Chemistry. 286(18). 16018–16029. 55 indexed citations

16.

Cheng, Qian & Jiandong Chen. (2011). The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation. Cell Cycle. 10(7). 1162–1166. 18 indexed citations

17.

Gilkes, Daniele M., Bo Li, Qian Cheng, et al.. (2011). Abnormal MDMX degradation in tumor cells due to ARF deficiency. Oncogene. 31(32). 3721–3732. 26 indexed citations

18.

Cheng, Qian & Jiandong Chen. (2010). Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle. 9(3). 472–478. 169 indexed citations

19.

Li, Baozong, Qian Cheng, Zhenyu Li, & Jiandong Chen. (2010). p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors. Cell Cycle. 9(7). 1411–1420. 55 indexed citations

20.

Cheng, Qian, Lihong Chen, Zhenyu Li, William S. Lane, & Jiandong Chen. (2009). ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. The EMBO Journal. 28(24). 3857–3867. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact